Miraqules will showcase its blood clotting technology at TechCrunch Disrupt 2025

Miraqules co-founder and CEO Sabir Hossain ever knew helium wanted to travel successful his father’s footsteps and tally his ain business. But helium ne'er thought he’d motorboat a biotech institution built astir a exertion that would person been capable to assistance his begetter aft a near-tragic mishap years earlier near him astir bleeding to death.

Bengaluru-based Miraqules developed a nanotechnology successful pulverization signifier that mimics humor clotting proteins. The humor clotting pulverization rapidly produces fibrous compounds astatine country somesthesia that are a precocious measurement to ratio and tin sorb humor rapidly erstwhile applied.

“This is simply a merchandise that volition springiness you feedback instantly,” Hossain told TechCrunch. “If determination is simply a idiosyncratic bleeding, you use it, and the bleeding stops. This full happening happens wrong 1 oregon 2 minutes.”

Miraqules is simply a Top 20 Startup Battlefield finalist and volition beryllium presenting this exertion connected signifier astatine TechCrunch Disrupt 2025, this week successful San Francisco.

Hossain said helium developed the exertion astir by accident.

He went to grad schoolhouse for biomedical engineering and started moving successful a probe laboratory focused connected biomaterials wherever his occupation was fundamentally to mimic the enactment of a doctorate student.

“I was truly atrocious astatine that, actually,” Hossain said. “Her occupation was to make 3D structures that volition assistance successful bony insubstantial growth, that could assistance successful bony generation. Every clip I was synthesizing that material, it was getting dismantled.”

One time helium took the dismantled particles and crushed it into a powder. He brought this pulverization to a radical moving connected humor clotting that was struggling to premix their solution decently to spot if it could assistance — and it worked.

“It clotted the full humor wrong possibly 5 to 10 seconds. I rushed to my prof and past from determination we started to deliberation astir what made it happen,” Hossain said. “We came up with the wholly caller process of combining off-the-shelf materials into a nanomaterial that mimics humor clotting proteins.”

Hossain past paired up with his puerility friend, Mubeen Midda, and they started trying to make the exertion truthful it could beryllium taken retired of the laboratory — with arsenic small backing arsenic possible.

Since then, the institution has been capable to unafraid 11 patents crossed 7 antithetic countries, including India, the United States, and Israel.

Miraqules’ tech is already being piloted successful a trauma attraction halfway successful India, and the institution expects to get its regulatory clearance successful India wrong the adjacent fewer months. It besides is connected way to person clearance from the U.S. Food and Drug Administration successful 2026.

“One happening we did from the beginning, we straight went to the U.S. FDA, determination is thing called pre-submission. We tried to get their feedback connected what different indispensable things that we request to bash to get this merchandise approved, that helped america a lot.”

The institution has reached these milestones with little than $700,000 successful superior raised, mostly from grants.

Miraqules is looking to ramp up deployment and aviator programs heading into adjacent year. It has already received imaginable involvement from 10 antithetic infirmary chains successful India and the Israeli Defense Forces.

If you privation to larn from Miraqules firsthand, and spot dozens of further pitches, be invaluable workshops, and marque the connections that thrust concern results, head present to larn much astir this year’s Disrupt, held October 27 to 29 successful San Francisco.